Indication
MSH2 Gene Mutation
1 clinical trial
1 drug
Clinical trial
A Phase II Study of PD-1 Inhibition for the Prevention of Colon Adenomas in Patients With Lynch Syndrome and a History of Partial ColectomyStatus: Terminated, Estimated PCD: 2021-01-25
Drug
T-VEC